Trial Profile
Efficacy and effects on quality of life (QOL) of tamsulosin versus naftopidil in elderly men with lower urinary tract symptoms (LUTS) and overactive bladder (OAB).
Status:
Not stated
Phase of Trial:
Phase IV
Latest Information Update: 05 Apr 2011
Price :
$35
*
At a glance
- Drugs Naftopidil (Primary) ; Tamsulosin (Primary)
- Indications Lower urinary tract symptoms; Overactive bladder
- Focus Therapeutic Use
- 22 Mar 2011 Results presented at the 26th Congress of the European Association of Urology.
- 05 Nov 2010 New trial record.